Cargando…
Developing prediction models for symptom severity around the time of discharge from a tertiary-care program for treatment-resistant psychosis
Antipsychotics are the only therapeutic class indicated in the symptomatic management of psychotic disorders. However, individuals diagnosed with schizophrenia or schizoaffective disorder may not always benefit from these first-line agents. This refractoriness to conventional treatment can be diffic...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282838/ https://www.ncbi.nlm.nih.gov/pubmed/37350999 http://dx.doi.org/10.3389/fpsyt.2023.1181740 |